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To the Editor: Previously, we reported the use of 
whole-genome sequencing to investigate a putative meth-
icillin-resistant Staphylococcus aureus (MRSA) outbreak 
in 2011 in the special care baby unit (SCBU) at the Cam-
bridge University Hospitals National Health Service Foun-
dation Trust (CUH) in the United Kingdom (1). The report 
identified 26 related cases of infection with or asymptom-
atic carriage of MRSA and showed that transmission oc-
curred within the SCBU, between mothers on a postnatal 
ward, and in the community; the outbreak apparently re-
solved at the end of 2011. The outbreak strain, sequence 
type (ST) 2371, was of a novel multilocus ST related to 
the dominant hospital-associated lineage in the UK (ST22, 
EMRSA-15), but unlike most ST22 strains, this strain 
was Panton-Valentine leucocidin–positive (2). Since then, 
ST2371 has been identified as a prevalent community-
associated MRSA clone in Southern India, and sporadic 
isolates have also been detected by whole-genome se-
quencing of MRSA in Denmark (3–5).
During April 2012–April 2013, we implemented ge-
nomic surveillance of MRSA isolated at the diagnostic mi-
crobiology laboratory at the CUH (F. Coll, unpub. data). 
From this, we noted that 10 isolates cultured from samples 
submitted from general practice (n = 7) and hospital wards 
(n = 3) during June 2012–February 2013 were classified as 
ST2371. Phylogenetic comparison between these 10 iso-
lates and the 45 isolates from the original outbreak dem-
onstrated that these strains were highly related (staphylo-
coccal cassette chromosome mec IVc, Panton-Valentine 
leucocidin–positive, staphylococcal protein A [spa] type 
852) (Figure).
We undertook an epidemiologic investigation to deter-
mine whether links could be identified between these new 
cases and the original outbreak. The 10 isolates were cultured 
from 5 patients (case-patients A–E), all of whom had a direct 
or indirect link to the 2011 outbreak. Case-patients from the 
2011 outbreak are identified by the alphanumeric code as-
signed during that outbreak investigation (e.g., P22) (1). 
Case-patients A and B were also case-patients in the 
original SCBU outbreak (P22 on the postnatal ward and 
P14 in the SCBU, respectively). Case-patient C was born at 
the CUH and was not screened for MRSA, but both parents 
were case-patients in the SCBU outbreak (P20 and P26). 
Case-patient D was born at the CUH and discharged when 5 
days old, which was 2 days before the birth of the presumed 
index case-patient of the original SCBU outbreak. The sam-
ple for the first isolate from case-patient D was collected 
almost 2 years later; acquisition could have occurred at the 
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Figure. Midpoint-rooted phylogenetic tree based on single-nucleotide polymorphisms (SNPs) in the core genome of methicillin-
resistant Staphylococcus aureus isolates from 2 investigations in the United Kingdom in 2011 and 2012–2013. Isolates were mapped 
against the EMRSA-15 reference genome. Open circles denote 20 individual colonies from a nasal swab culture taken  
from a healthcare worker during 
an outbreak in a hospital special 
care baby unit (SCBU) in 2011. 
Gray shaded circles denote 
isolates from 25 patients and 
their family members investigated 
during the 2011 outbreak. Black 
circles denote 10 isolates from 5 
persons (case-patients A–E) from 
whom microbiological samples 
were taken during the 2012–2013 
study. Numbers prefixed by P 
indicate the original study number 
used for each case during the 
2011 outbreak investigation. 
Multiple samples from the 
same patient are identified by 
an underscore followed by the 
sample number. Two case-
patients (P22/A and P14/B) were 
included in both outbreaks.  
Scale bar indicates SNPs.
CUH or from subsequent contact with unsuspected carriers 
in the case-patient’s family or the community. On the basis 
of a matching surname, case-patient E was determined to be 
a member of the same family as case-patients P20, P26, and 
likely C. Soft tissue infection was documented in all 5 case-
patients, supporting the original observation that ST2371 is 
associated with disease. Evidence of familial transmission 
in the original outbreak is further supported by transmission 
between case-patients P20, P26, C, and E. Furthermore, 2 
case-patients infected during the original outbreak, P22/A 
and P14/B, continued to experience disease signs and symp-
toms for >15 months after their initial diagnosis.
Our data highlight the role of hospitals as reservoirs of 
MRSA and subsequent failure to track the entry and spread 
of MRSA in the community. MRSA decolonization was 
advised in all cases in the original outbreak, but this pro-
cess clearly proved ineffective for case-patients A and B. 
Potential explanations include not implementing or com-
pleting the course of decolonization; failed decolonization; 
or limiting decolonization to only some members of an af-
fected family. Although the outbreak in the hospital ward 
was resolved, the lack of a systematic surveillance program 
to monitor the incidence of noninvasive MRSA infections 
among the case-patients’ contacts and the community al-
lowed this novel lineage to continue to cause disease in a 
group of linked persons. Considering recommendations to 
move from universal to targeted MRSA screening in hospi-
tals in England (6), more active surveillance of any identi-
fied case-patients or carriers of MRSA in the community 
may be warranted.
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To the Editor: In Queensland, Australia, a steady in-
crease in community-acquired (CA) Clostridium difficile 
infections (CDI) during 2003–2012 could not be explained 
by patients’ demographic characteristics or environmental 
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